Hemab Therapeutics Holdings, Inc. Common Stock reported earnings of -$ 0.58 per COAG share on Nov 10, 2026, beating analysts' expectations by
| Report Date | Nov 10, 2026 |
|---|---|
| Forecasted EPS | -$ 0.50 |
| Earnings Per Share (Surprise) | -$ 0.58 (-$ 0.08) |
Out of the last 4 earnings reporting periods, Hemab Therapeutics Holdings, Inc. Common Stock beat analysts’ expectations 1 times and fell short of expectations 3 time(s). Hemab Therapeutics Holdings, Inc. Common Stock reported earnings per share of -$ 0.58 in the last report falling to reach an estimated EPS of -$ 0.50 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 10, 2026 | -$ 0.50 | -$ 0.58 | - | - |
| Aug 20, 2026 | -$ 0.56 | - | - | |
| Aug 11, 2026 | -$ 0.73 | -$ 0.80 | - | - |
| May 21, 2026 | -$ 23.25 | -$ 23.98 | - | - |
Hemab Therapeutics Holdings, Inc. Common Stock’s stock was trading at $ 42.81 on Nov 9, 2026 a day before the last earnings report was released.Following the release of the earnings report, COAG’s price decreased to $ 39.33 on Nov 11, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 10, 2026 | -$ 0.58 | $ 42.81 | $ 39.33 | |
| Aug 20, 2026 | | $ 51.66 | $ 49.16 | |
| Aug 11, 2026 | -$ 0.80 | $ 49.87 | $ 53.48 | |
| May 21, 2026 | -$ 23.98 | $ 26.47 | $ 25.89 |
Hemab Therapeutics Holdings, Inc. Common Stock released its most recent earnings reports in November 2026, August 2026, August 2026, May 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Hemab Therapeutics Holdings, Inc. Common Stock missed analysts’ expectations during the last earnings period by
